Finally, we also confirmed the relationship between SRSF11 expression and sorafenib sensitivity using clinical samples and cellular CCK-8 assays, and all these data strongly supported the potential value of SRSF score for predicting drug sensitivity in HCC. Here, SRSF11 is linked to hepatocellular carcinoma.